JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Acar, C.
Right arrow Articles by Buckberg, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Acar, C.
Right arrow Articles by Buckberg, G. D.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 284-293, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate

C Acar, MT Partington and GD Buckberg
UCLA School of Medicine, Department of Surgery 90024-1741.

HYPOTHESIS: Initial reoxygenation with blood cardioplegic solution produces better regional recovery than with Fluosol DA cardioplegic solution (Green Cross Corporation, Osaka, Japan) because blood cardioplegia ensures delivery of important blood components (i.e., plasma and red blood cells) that limit reperfusion damage. METHODS: Twenty-five dogs underwent 2 hours of ligation of the left anterior descending coronary artery followed by controlled reperfusion at 50 mm Hg through an internal mammary graft on total vented bypass. Five dogs received normal blood reperfusion, 10 dogs received a 20-minute reperfusion with Fluosol DA 20% cardioplegic solution, and 10 others received a blood cardioplegic reperfusate of identical composition (i.e., pH, calcium, potassium, glucose, osmolarity). Regional oxygen consumption was measured during reperfusion, and segmental shortening (ultrasonic crystals), tissue water content, and histochemical damage (triphenyltetrazolium chloride stain) were assessed 2 hours later. RESULTS: Reperfusion with normal blood failed to restore contractile function (3% systolic shortening), caused severe edema (81% water content), and caused marked histochemical damage (48% triphenyltetrazolium chloride nonstaining). Hearts reperfused with Fluosol DA cardioplegic solution did not take up as much oxygen as hearts receiving blood cardioplegic reperfusion (37 versus 54 ml/100 gm, p less than 0.05). Blood cardioplegia was superior to Fluosol DA cardioplegia in recovery of segmental contractility (69% versus 34% systolic shortening, p less than 0.05), produced less edema (79.5% versus 80.9% water content, p less than 0.05), and produced less histochemical damage with triphenyltetrazolium chloride (11% versus 40% area of nonstaining/area at risk, p less than 0.05). CONCLUSIONS: Initial reperfusion with a blood cardioplegic solution ensures better oxygen utilization, superior recovery of regional contractility, and less tissue damage than Fluosol DA cardioplegic reperfusion. These data emphasize the importance of including blood components (plasma or red blood cells) in the oxygenated cardioplegic reperfusate to limit reperfusion injury.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-Q. Zhao, J. S. Corvera, M. E. Halkos, F. Kerendi, N.-P. Wang, R. A. Guyton, and J. Vinten-Johansen
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning
Am J Physiol Heart Circ Physiol, August 1, 2003; 285(2): H579 - H588.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
G. A Ortolano, G. S Aldea, K. Lilly, P. O'Gara, J. D Alkon, F. Madera, T. Murad, C. P Altenbern, C. S Tritt, A. Capetandes, et al.
A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects
Perfusion, March 1, 2002; 17(2_suppl): 53 - 62.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Habazettl, B. W. Palmisano, B. M. Graf, D. L. Roerig, Z. J. Bosnjak, and D. F. Stowe
IMPROVEMENT IN FUNCTIONAL RECOVERY OF THE ISOLATED GUINEA PIG HEART AFTER HYPERKALEMIC REPERFUSION WITH ADENOSINE
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 74 - 84.
[Abstract] [Full Text]


Home page
PerfusionHome page
A. Marchbank
Fluorocarbon emulsions
Perfusion, March 1, 1995; 10(2): 67 - 88.
[PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. T. Smolenski, A.-M. L. Seymour, and M. H. Yacoub
Dynamics of energy metabolism in the transplanted human heart during reperfusion
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 938 - 945.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The American Association for Thoracic Surgery.